Literature DB >> 24569790

Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.

Barbara Heidenreich1, Eduardo Nagore2, P Sivaramakrishna Rachakonda3, Zaida Garcia-Casado4, Celia Requena5, Victor Traves6, Jürgen Becker7, Nadem Soufir8, Kari Hemminki9, Rajiv Kumar3.   

Abstract

We previously reported a disease segregating causal germline mutation in a melanoma family and recurrent somatic mutations in metastasized tumours from unrelated patients in the core promoter region of the telomerase reverse transcriptase (TERT) gene. Here we show that the TERT promoter mutations, besides causing an increased gene expression, associate with increased patient age, increased Breslow thickness and tumour ulceration in 287 primary melanomas. The mutations are more frequent at both intermittently and chronically sun-exposed sites than non-exposed sites and tend to co-occur with BRAF and CDKN2A alterations. The association with parameters generally connected with poor outcome, coupled with high recurrence and mechanistic relevance, raises the possibility of the eventual use of TERT promoter mutations in the disease management.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24569790     DOI: 10.1038/ncomms4401

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  70 in total

1.  Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.

Authors:  Sumit Borah; Linghe Xi; Arthur J Zaug; Natasha M Powell; Garrett M Dancik; Scott B Cohen; James C Costello; Dan Theodorescu; Thomas R Cech
Journal:  Science       Date:  2015-02-05       Impact factor: 47.728

2.  Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis.

Authors:  Nancy E Thomas; Sharon N Edmiston; Yihsuan S Tsai; Joel S Parker; Paul B Googe; Klaus J Busam; Glynis A Scott; Daniel C Zedek; Eloise A Parrish; Honglin Hao; Nathaniel A Slater; Michelle V Pearlstein; Jill S Frank; Pei Fen Kuan; David W Ollila; Kathleen Conway
Journal:  Am J Dermatopathol       Date:  2019-04       Impact factor: 1.533

Review 3.  A second chance for telomerase reverse transcriptase in anticancer immunotherapy.

Authors:  Maurizio Zanetti
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

4.  Association of TERT promoter mutations with telomerase expression in melanoma.

Authors:  Seungjae Lee; Patricia Opresko; Alberto Pappo; John M Kirkwood; Armita Bahrami
Journal:  Pigment Cell Melanoma Res       Date:  2016-05       Impact factor: 4.693

5.  Prognostic Value of TERT Alterations, Mutational and Copy Number Alterations Burden in Urothelial Carcinoma.

Authors:  Sumit Isharwal; François Audenet; Esther Drill; Eugene J Pietzak; Gopa Iyer; Irina Ostrovnaya; Eugene Cha; Timothy Donahue; Maria Arcila; Gowtham Jayakumaran; Michael F Berger; Jonathan E Rosenberg; Dean F Bajorin; Jonathan Coleman; Guido Dalbagni; Victor E Reuter; Bernard H Bochner; David B Solit; Hikmat A Al-Ahmadie
Journal:  Eur Urol Focus       Date:  2017-08-10

Review 6.  TERRA Gene Expression in Gastric Cancer: Role of hTERT.

Authors:  Sogand Vahidi; Ali Akbar Samadani
Journal:  J Gastrointest Cancer       Date:  2021-01-07

7.  A primary melanoma and its asynchronous metastasis highlight the role of BRAF, CDKN2A, and TERT.

Authors:  Gregory A Hosler; Teresa Davoli; Ilgen Mender; Brandon Litzner; Jaehyuk Choi; Payal Kapur; Jerry W Shay; Richard C Wang
Journal:  J Cutan Pathol       Date:  2014-12-11       Impact factor: 1.587

8.  Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression.

Authors:  Ekta Khattar; Pavanish Kumar; Chia Yi Liu; Semih Can Akıncılar; Anandhkumar Raju; Manikandan Lakshmanan; Julien Jean Pierre Maury; Yu Qiang; Shang Li; Ern Yu Tan; Kam M Hui; Ming Shi; Yuin Han Loh; Vinay Tergaonkar
Journal:  J Clin Invest       Date:  2016-09-19       Impact factor: 14.808

9.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

Review 10.  Germline mutations predisposing to melanoma.

Authors:  Atrin Toussi; Nicole Mans; Jeanna Welborn; Maija Kiuru
Journal:  J Cutan Pathol       Date:  2020-05-11       Impact factor: 1.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.